BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

341 related articles for article (PubMed ID: 24461309)

  • 1. Evidence of an association between 10/10 genotype of DAT1 and endophenotypes of attention deficit/hyperactivity disorder.
    Agudelo JA; Gálvez JM; Fonseca DJ; Mateus HE; Talero-Gutiérrez C; Velez-Van-Meerbeke A
    Neurologia; 2015 Apr; 30(3):137-43. PubMed ID: 24461309
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A 40-bp VNTR polymorphism in the 3'-untranslated region of DAT1/SLC6A3 is associated with ADHD but not with alcoholism.
    Šerý O; Paclt I; Drtílková I; Theiner P; Kopečková M; Zvolský P; Balcar VJ
    Behav Brain Funct; 2015 Jun; 11():21. PubMed ID: 26058807
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The VNTR polymorphism in the human dopamine transporter gene: improved detection and absence of association of VNTR alleles with attention-deficit hyperactivity disorder.
    Simsek M; Al-Sharbati M; Al-Adawi S; Lawatia K
    Genet Test; 2006; 10(1):31-4. PubMed ID: 16545000
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Spatial attentional bias as a marker of genetic risk, symptom severity, and stimulant response in ADHD.
    Bellgrove MA; Barry E; Johnson KA; Cox M; Dáibhis A; Daly M; Hawi Z; Lambert D; Fitzgerald M; McNicholas F; Robertson IH; Gill M; Kirley A
    Neuropsychopharmacology; 2008 Sep; 33(10):2536-45. PubMed ID: 18046306
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A meta-analysis of association studies between the 10-repeat allele of a VNTR polymorphism in the 3'-UTR of dopamine transporter gene and attention deficit hyperactivity disorder.
    Yang B; Chan RC; Jing J; Li T; Sham P; Chen RY
    Am J Med Genet B Neuropsychiatr Genet; 2007 Jun; 144B(4):541-50. PubMed ID: 17440978
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of the dopamine transporter (DAT1) 10/10-repeat genotype with ADHD symptoms and response inhibition in a general population sample.
    Cornish KM; Manly T; Savage R; Swanson J; Morisano D; Butler N; Grant C; Cross G; Bentley L; Hollis CP
    Mol Psychiatry; 2005 Jul; 10(7):686-98. PubMed ID: 15809660
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association study and a systematic meta-analysis of the VNTR polymorphism in the 3'-UTR of dopamine transporter gene and attention-deficit hyperactivity disorder.
    Grünblatt E; Werling AM; Roth A; Romanos M; Walitza S
    J Neural Transm (Vienna); 2019 Apr; 126(4):517-529. PubMed ID: 30923918
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interacting effects of the dopamine transporter gene and psychosocial adversity on attention-deficit/hyperactivity disorder symptoms among 15-year-olds from a high-risk community sample.
    Laucht M; Skowronek MH; Becker K; Schmidt MH; Esser G; Schulze TG; Rietschel M
    Arch Gen Psychiatry; 2007 May; 64(5):585-90. PubMed ID: 17485610
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dissecting the attention deficit hyperactivity disorder (ADHD) phenotype: sustained attention, response variability and spatial attentional asymmetries in relation to dopamine transporter (DAT1) genotype.
    Bellgrove MA; Hawi Z; Kirley A; Gill M; Robertson IH
    Neuropsychologia; 2005; 43(13):1847-57. PubMed ID: 16168728
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The variable number of tandem repeats element in DAT1 regulates in vitro dopamine transporter density.
    VanNess SH; Owens MJ; Kilts CD
    BMC Genet; 2005 Nov; 6():55. PubMed ID: 16309561
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Association studies of dopamine D4 receptor gene and dopamine transporter gene polymorphisms in Han Chinese patients with attention deficit hyperactivity disorder].
    Qian Q; Wang Y; Li J; Yang L; Wang B; Zhou R
    Beijing Da Xue Xue Bao Yi Xue Ban; 2003 Aug; 35(4):412-8. PubMed ID: 12947560
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sequence variation in the 3'-untranslated region of the dopamine transporter gene and attention-deficit hyperactivity disorder (ADHD).
    Feng Y; Wigg KG; Makkar R; Ickowicz A; Pathare T; Tannock R; Roberts W; Malone M; Kennedy JL; Schachar R; Barr CL
    Am J Med Genet B Neuropsychiatr Genet; 2005 Nov; 139B(1):1-6. PubMed ID: 16082693
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Haplotype study of three polymorphisms at the dopamine transporter locus confirm linkage to attention-deficit/hyperactivity disorder.
    Barr CL; Xu C; Kroft J; Feng Y; Wigg K; Zai G; Tannock R; Schachar R; Malone M; Roberts W; Nöthen MM; Grünhage F; Vandenbergh DJ; Uhl G; Sunohara G; King N; Kennedy JL
    Biol Psychiatry; 2001 Feb; 49(4):333-9. PubMed ID: 11239904
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of the DAT1 polymorphism with attention deficit hyperactivity disorder (ADHD): a family-based approach.
    Lim MH; Kim HW; Paik KC; Cho SC; Yoon DY; Lee HJ
    Am J Med Genet B Neuropsychiatr Genet; 2006 Apr; 141B(3):309-11. PubMed ID: 16526026
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic interaction analysis for DRD4 and DAT1 genes in a group of Mexican ADHD patients.
    Gabriela ML; John DG; Magdalena BV; Ariadna GS; Francisco de LP; Liz SM; Lino PC; Josefina RG; Ernesto RZ; Carlos CF
    Neurosci Lett; 2009 Feb; 451(3):257-60. PubMed ID: 19146920
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dopamine transporter genotype and methylphenidate dose response in children with ADHD.
    Stein MA; Waldman ID; Sarampote CS; Seymour KE; Robb AS; Conlon C; Kim SJ; Cook EH
    Neuropsychopharmacology; 2005 Jul; 30(7):1374-82. PubMed ID: 15827573
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between dopamine transporter (DAT1) genotype, left-sided inattention, and an enhanced response to methylphenidate in attention-deficit hyperactivity disorder.
    Bellgrove MA; Hawi Z; Kirley A; Fitzgerald M; Gill M; Robertson IH
    Neuropsychopharmacology; 2005 Dec; 30(12):2290-7. PubMed ID: 16123773
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dopamine transporter 3'-UTR VNTR genotype and ADHD: a pharmaco-behavioural genetic study with methylphenidate.
    Joober R; Grizenko N; Sengupta S; Amor LB; Schmitz N; Schwartz G; Karama S; Lageix P; Fathalli F; Torkaman-Zehi A; Ter Stepanian M
    Neuropsychopharmacology; 2007 Jun; 32(6):1370-6. PubMed ID: 17063150
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Attention-deficit/hyperactivity disorder (ADHD) association with the DAT1 core promoter -67 T allele.
    Ohadi M; Shirazi E; Tehranidoosti M; Moghimi N; Keikhaee MR; Ehssani S; Aghajani A; Najmabadi H
    Brain Res; 2006 Jul; 1101(1):1-4. PubMed ID: 16782077
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between the DAT1 gene and spatial working memory in attention deficit hyperactivity disorder.
    Shang CY; Gau SS
    Int J Neuropsychopharmacol; 2014 Jan; 17(1):9-21. PubMed ID: 24008096
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.